Stock LUPIN LUPIN LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Lupin Limited

Equities

LUPIN

INE326A01037

Market Closed - Bombay S.E.
Other stock markets
 06:00:49 2024-05-17 am EDT 		5-day change 1st Jan Change
1,652 INR -0.56% Intraday chart for Lupin Limited +2.65% +24.90%
May. 13 Lupin Relaunches Mirabegron ER Tablets in US MT
May. 09 Nomura Adjusts Lupin’s Price Target to INR1,952 From INR1,949, Keeps at Buy MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lupin : May 16, 2024 Lupin Receives Approval from U.S. FDA for Midostaurin Capsules
PU
Lupin : May 15, 2024 Lupin Achieves Significant Milestone with ISO 14001 and ISO 45001 Certification Across All its Indian Manufacturing Sites, R&D Center and Corporate Office
PU
Lupin Relaunches Mirabegron ER Tablets in US
MT
Nomura Adjusts Lupin’s Price Target to INR1,952 From INR1,949, Keeps at Buy
MT
Lupin : May 9, 2024 Jeffrey Kindler and Alfonso Zulueta Join Lupin Board as Independent Directors
PU
Lupin Limited Announces Board Appointments
CI
Jefferies Adjusts Lupin’s Price Target to INR1,535 From INR1,460 Keeps at Hold
MT
Transcript : Lupin Limited, Q4 2024 Earnings Call, May 07, 2024
Lupin's Consolidated Profit Climbs in Fiscal Q4; Shares Dip 4%
MT
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
RE
Lupin : May 6, 2024 Lupin Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP
PU
Lupin Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Lupin Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Lupin : May 3, 2024 Lupin Launches Rymti® Biosimilar Etanercept in Canada
PU
Lupin Limited Receives an Order from Office of the State Tax Inspector, Jurisdiction: Ghatak 56: Range - 14: Division - 6: Gujarat
CI
Lupin : April 25, 2024 Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.5%
PU
Lupin : April 25, 2024 Lupin Digital Health’s Lyfe Platform Receives Class C Medical Device License from CDSCO
PU
Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility
MT
Lupin : April 23, 2024 Lupin Receives EIR from U.S. FDA for its Aurangabad Manufacturing Facility
PU
Lupin : April 22, 2024 Lupin Launches Mirabegron Extended-Release Tablets in the United States
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LUPIN Stock
  4. News Lupin Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW